|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing
8 [+ c8 R9 }) ^/ x- DA Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex 3 F5 W) {3 q" }1 N' ] U, ~
Acute Complications of Stem Cell Transplant 6 B; o! f2 `" Y
Adhesion within the stem cell niches
, v4 ?: q0 O! k. V" d- BAllogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma
7 F# k) s+ c( W; ]Beliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research
4 m1 O* j* G/ s* X6 G2 r ibone-What is the true nature of the osteoblastic hematopoietic stem cell niche
; R7 g0 S$ |% G3 yApoptosis signaling in cancer stem cells ; g; M) g6 m0 M+ G% W* C8 A
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
7 C0 H! S& u; ]# _% d3 ]# p B" m/ @Recurrence cancer stem cells
: c( }' b5 D1 V- eStem cells in melanoma development " h% B9 F7 J" L, ?: \3 n
Competitive Interactions Between Cells 9 p7 L- s% G# F+ b( H& _, q
Cord blood stem cells for hematopoietic stem cell transplantation in the UK
$ L% [$ \6 [, L! k+ r6 Q2 VA chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke ' ?# N" y$ w9 r- Q" N: @
Cardiac stem-progenitor cells, secreted proteins, and proteomics + C. A4 c; Z6 _" z& I
Cardiovascular stem cells in regenerative medicine
0 f2 j* e: {) E% REndogenous stem cells in patients undergoing coronary artery bypass D" ^3 n! T0 R/ Y# n" F' p7 K
Enhancing cardiac stem cell differentiation into cardiomyocytes
5 c2 z. H/ k; R0 UIn Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
+ Q5 P: P. z/ cResident cardiac stem-progenitor cells for cardiac regeneration
* c* A% E) g' z0 Y) M9 AS1+ Stem Cell Survival and Engraftment in the Infarcted Heart
6 L! f5 Q/ N: |' I3 [Stem cell engineering for treatment of heart diseases
5 S3 S$ m* L2 }/ ?0 E. ~0 qStem cell therapy in acute myocardial infarction
3 U5 m8 v- {. N. QStem Cell Therapy Is Proarrhythmic 4 j: c& f) { ~( X7 P$ R
Stem Cell Therapy-A Primer for Interventionalists and Imagers
- s2 |) _+ s2 Z; S4 U8 Ndiabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes : t9 r2 |- X- g: G; H) }, A
Embryonic stem cells as a model for cardiac development and disease
0 X! C( N* }' eEpigenetic dynamics of stem cells and cell lineage commitment , U3 S# u2 {- _# y5 H1 \1 h
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection
# J4 e0 r. `" A1 t" y0 vExpanding Indications for Stem Cell Transplantation
. x8 N9 |% B0 Z \# M iFatal nephrotic syndrome complicating allogeneic stem cell transplantation
: q* v+ B+ P1 hGrowth Factors, Matrices, and Forces Combine and Control Stem Cells 9 x8 T: a8 z* O; V. w3 x- {& O
Hematopoietic stem cell origin of adipocytes + u2 _: l4 ]: ], W$ w$ x9 H, m$ c
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis
% o1 P. u, ^+ P6 @ MLong-term microcarrier suspension cultures of human embryonic stem cells
% J& ~# H, A% G. U, L( h! UMicrosphere-based tracing and molecular delivery in embryonic stem cells 4 b/ G F8 j" A# P
Microspheres as a vehicle for biomolecule delivery to neural stem cells
5 b' V7 x8 y, A; u# p, A( SNew insights into liver stem cells
; z2 m7 w/ {9 |' S! u' h8 wA NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS ) A: A# M* d2 _# W% ?
Regeneration of the ischemic brain by engineered stem cells
' r' a, j1 \2 y9 Z% @ ^7 x0 V" Z2 p) lStem cell-based cell replacement strategies for the central nervous system / [1 A. a( \8 F4 ?; V9 Z
Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
a3 d( p( O q5 OPeripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
; L/ ?( ~ N$ A/ R( Y& z9 _Pluripotent stem cells as new drugs
+ P# |1 e+ [7 u, g- Oregenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine $ C8 I% |* W+ F7 g. S4 G
respir-Cell therapy approaches for lung diseases ) y; n7 F& }+ J' r
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
5 @" B% ~) _6 T% c+ w/ s: KRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
# T+ f9 D4 h9 g3 ?Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma - y- ]! y/ e: H5 L& h% A( v- t, H
Status of adult marrow stem cell biology 4 @$ l' m7 M) A! o
Stem cell and genetic therapies for the fetus 7 j& i+ F+ r9 I4 ] R3 F
Stem cell decision making and critical-like exploratory networks x; j/ N5 o: X9 c% k8 `' T
Stem Cell Therapy for Heart Failure
5 F8 _" |4 J( a$ J. N3 j) Y; u# NStem Cell Therapy for the Kidney
/ o; z( A+ z: V5 V) UStem Cells and Liver Regeneration & Y* Q3 Z5 }: Y" Z2 x" C) F
Stem cells, microenvironment mechanics, and growth factor activation
# W% Z" N. Q, h, }) y& q8 F9 i. pStem cells-The highs and lows of pluripotency
& k# [& D( y5 i, q5 XSuccessful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation
7 K, l. c8 i) @3 I3 Q$ T; JSurvivorship Issues in Hematopoietic Stem Cell Transplantation
' X* W) o% q) A% z" qTelomere length maintenance in stem cell populations 2 X1 }( [- h* V! g
Teratoma formation by human embryonic stem cells
* c3 P- u3 X4 {7 v1 nThe Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation 1 [! G7 e6 [) p* c( ?" }7 a
The Increasing Complexity of the Cancer Stem Cell Paradigm # e9 @3 ], {% g
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
3 C% d) N& B( e2 I4 U4 c: uTranscripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation
- @) \+ e, R) \Variation in the safety of induced pluripotent stem cell lines
% i |6 ?2 ^) d% H- D% Q( JA niche play for stem cells
. n$ k: f6 Q# L8 K4 i8 x7 @9 t% jA niche play for stem cells 5 x4 t \* b3 U [" _
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells 1 }6 r6 \" X9 e) }0 D* k8 ~
Acute Complications of Stem Cell Transplant
% H, u' x) \( N* d$ w2 GAdipose-Derived Stem Cells 0 i: r- ]+ P# |
Adult neural stem cells in the mammalian central nervous system 3 x. ]7 ]1 E+ O0 c5 c- a# d9 X9 Q
Apoptosis Signaling in Cancer Stem Cells 3 ^- N& V4 S& n' l, z: ?
Automated selection and collection of pluripotent stem cell colonies using the CellCelector
# D! [, k) H! H. K q! R; IBCOR regulates mesenchymal stem cell function by epigenetic mechanisms
$ v/ ` H: m1 c5 ^/ |5 oBmi-1, stem cells and cancer . X" ~1 X: _+ ?! C, T+ K \: [+ U
cancer stem cell marker
- R' _+ Z. x: Q# W# lCancer stem cells $ ]; p- }/ e$ f- N, W$ ^: q2 z% E
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases ) ^8 a' `# Y: P9 K% N
Competitive Interactions Between Cells-Death, Growth, and Geography
4 T4 ]' X. y9 B+ _! {+ HPotential novel pharmacological therapies for myocardial remodelling
! A5 K; o/ \4 D7 N: i G) DDisease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells # N' E# E. h" |9 V0 J4 x( G
Elite and stochastic models for induced pluripotent stem cell generation
' M* f& F5 [$ u: P5 N1 P r& eEmbryonic stem (ES) cell-derived cardiomyocytes
: J' k6 x& x. P. a7 A' iEmerging Immunology of Stem Cell Transplantation 7 m+ V1 Y V) T i
Ethical Issues in Stem Cell Research
( x# J" e, u; v+ J0 u5 Z# jFDA Regulation of Stem Cell Based Products $ N# p7 L5 @* [
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
0 \* s* S* h. k9 ~4 z9 e- zHuman embryonic stem cells and cardiac repair 9 O8 h3 k. C( {- A% L$ p( M
Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair
; }5 g2 A& U2 A$ ?( lHuman ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
$ |- I3 g! \" S) ~! d& d6 }IFN-wakes up sleeping hematopoietic stem cells
: Y3 [+ @* z1 s# T1 ~Imaging Stem Cell Implant for Cellular-Based Therapies
7 C; W% X* p, c* R' g" m/ c7 D h5 N1 s* UImplications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy * K& }5 z: ~% O$ E: f2 x w/ h
Induced pluripotent stem cells and the stability of the differentiated state
8 S9 k% M( G6 ^Instructing an Embryonic Stem Cell-Derived Oocyte Fate
- u+ x3 p; N3 PMedical Innovation Versus Stem Cell Tourism
9 p% E L) f1 V% OIn Search of Adrenocortical Stem and Progenitor Cells 9 y$ c8 S. p. v( D* k
Neural stem cells aplenty / L7 F+ b! d1 K* G8 ]
Pancreatic cancer stem cells
$ m/ ~0 S7 g; m3 s6 O; hParacrine Mechanisms in Adult Stem Cell Signaling and Therapy . k' Z; _) y h
Psychological Issues of Stem Cell Transplant 3 J+ Z. o- Q/ O3 g) C
Regeneration of the ischemic brain by engineered stem cells
" E1 {+ w( R2 VRegulatory circuits underlying pluripotency and reprogramming
2 u: X6 ^/ j# r3 x4 F) I. Lrespir-Cell therapy approaches for lung diseases
3 u$ _0 H" n, vRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation n9 ?5 U w! F. p& N! I
specific microRNAs promote induced pluripotency
# ^8 n( ~. K: W4 g" |; U3 lStem Cell Therapy for the Kidney
+ ]/ C' K6 R& N$ l: e) ustem cell therapy in cutaneous wound healing
& n& N0 }3 F. t9 N& z0 D* i3 IStem cell therapy perspectives for type 1 diabetes
3 g+ q% p- Y7 x5 c, ZStem Cells and Liver Regeneration # p- v7 e' S' p! N3 q1 J! T
Stem cells based transplantation for cardiovascular diseases in China
9 e$ m) r& z) k' z. W8 y2 e2 LStem-cell therapy faces more scrutiny in China 3 ]7 T. u( M6 r* I' e
Steps to the Clinic
. x& d# u$ K( H- M8 `# pStepwise differentiation of pluripotent stem cells into retinal cells 2 C6 p9 Q# }0 e9 ^! Z6 P# D5 @8 Q
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche - ]% i6 M; {% ]( p
The Increasing Complexity of the Cancer Stem Cell Paradigm . ~0 X6 f" z0 ~* G2 Z
The NIH Draft Guidelines on Human Stem Cell Research
0 }8 |# ]$ h9 s' PThe pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting 6 o# G. E) a( Q$ d3 m
The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair " W/ H2 U" d9 r8 U; ?2 G
The tumor stem cell concept
/ b9 _9 j' `# c9 G" H" w! z$ yUmbilical cord blood stem cells-Towards a proteomic approach / F* G/ }7 M9 }# [5 T6 k9 J- l- ?
US regulator wades into stem cell therapies for heart disease / ^1 B0 n2 ]# H# ^. g
Apoptosis Signaling in Cancer Stem Cells / C$ N: I, z, C
Pancreatic cancer stem cells
0 d6 g" R+ i1 v; I. k9 d' |Acute Complications of Stem Cell Transplant
. R3 k9 A6 O8 |Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma ' v* d, l$ L4 F9 A; m/ m# `( }
Deconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine
- i! h0 G8 e0 l% o3 D. k- }Emerging Immunology of Stem Cell Transplantation # ]( I! ~8 i. f& Y5 H
Management Issues In Hematopoietic Stem Cell Transplantation . B) g7 z8 T4 P+ r7 e8 z6 l
Psychological Issues of Stem Cell Transplant
0 z+ f9 W0 B2 D, NThe NIH Draft Guidelines on Human Stem Cell Research
: I, z b8 ~3 a: _, uThe therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
0 [4 \1 y! D/ ?8 e% CBone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction
) v) n' x+ z* l$ M$ n. sEmbryonic stem (ES) cell-derived cardiomyocytes
( Q2 u. N- x. g4 K+ gEmbryonic stem cells as a model for cardiac development and disease
7 B1 T) i3 L- H1 jEndogenous stem cells in patients undergoing coronary artery bypass graft surgery
0 {/ e3 Q8 m# \4 V. gHuman embryonic stem cells and cardiac repair
- |$ u- h' Z c" f" A, SPercutaneous intramyocardial stem cell injection in patients with acute myocardial infarction ) f W% `6 C, H1 J, B9 a- D! c6 ]8 R
Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair
: Z+ J# q1 y- [* C0 KStem Cell Therapy for Heart Failure * e0 F# @6 {4 t( A. ^5 ]/ Z
Epithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation
( t3 L% C% B' _* |8 A/ @5 {Full text access provided to Peking university 2 d+ V% G1 ?) f, [, ^% y2 H
Improving stem cell mobilization strategies-future directions
+ P% J6 g9 k1 b- HInduced pluripotent stem cells from a spinal muscular atrophy patient
' ]6 E/ J' R ]- P" k5 b$ PInduced pluripotent stem cells-current progress and potential for regenerative medicine
. `5 v F7 C* tInterferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion + q0 v: t8 R9 e; ^; W. L
Low-risk reprogramming
# Y/ l& V" l( Q7 E; L2 WMolecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells : V/ j J* O) c- o I% l
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells : j* r7 v& w: a+ e
Pluripotent stem cells as new drugs
5 B; u u4 u) ] p* f% P1 M/ Wproteome-Umbilical cord blood stem cells-Towards a proteomic approach
r$ t- ?4 S+ L& g8 R" O- j! R7 {Regeneration of the ischemic brain by engineered stem cells
0 m- d9 J" u v; Y1 fResearchers Generally Happy With Final Stem Cell Rules
& f" N$ N/ `3 T pStem Cell Niche + ^5 T" g: ^ [+ q. i. _
Stem cell therapy perspectives for type 1 diabetes
5 A6 m/ a6 \ tStem Cells and Liver Regeneration
( N+ D7 K8 u" dStem cells-Fast and furious ' v/ v) Z1 F; [) [, T
Survivorship Issues in Hematopoietic Stem Cell Transplantation e0 u2 u p0 V
The NIH Draft Guidelines on Human Stem Cell Research
. U8 m V/ {( o4 Q; \$ fThe origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
8 E9 k/ L! b: J3 BUS stem-cell research expands ( s5 [% l7 H+ H8 R1 t! h
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
9 Q0 B( V0 b) N4 J* o. t. FWnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
